Runshan (Will) Jiang

His research involves the development of in vivo solid phase micro-extraction (SPME) acupuncture needles intended for the extraction of various organic molecules and biomolecules from biological matrices. Extractions are coupled with LC-MS/MS, Microfluidic Open Interface (MOI) direct MS, and LC-High Resolution MS end-point detection methods. His current research focuses on the extraction and monitoring of Doxorubicin, a chemotherapeutic agent, and its metabolites from animal and human lungs undergoing isolated lung perfusion (ILP) as an emergency treatment of lung metastases using SPME acupuncture needles.